News
With tariffs threatening the sector’s low-cost sourcing playbook, pharma is being forced to rethink supply chain resilience ...
UCB has shared promising results from a late-stage study of fenfluramine in patients with an ultra-rare form of epilepsy. The ...
Genesis Research Group, a leading provider of tech-enabled real-world evidence (RWE), health economics and outcomes research ...
Crouch most recently served as therapeutic lead, oncology and specialty medicine for international developed markets at ...
Using technology to make your exhibitions stand out in 2025. In today’s fast-paced experience economy, pharma companies can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results